Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
665.00    -7.00 (-1.04%)
Bid:
664.00
Ask:
666.00
Spread: 2.00 (0.301%)
Market Cap: £541.28m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

12 Aug 2025 16:29

RNS Number : 0489V
Bloomsbury Publishing PLC
12 August 2025
 

12 August 2025

 

Bloomsbury Publishing Plc (the "Company")

 

Director/PDMR Shareholdings

 

Sale of shares following the vesting and exercise of options under the Bloomsbury Publishing Plc 2014 Performance Share Plan ("2014 PSP")

 

The Company announced on 11 August 2025 that the conditional share award granted in August 2022 under the 2014 PSP vested at 87% of the maximum on 10 August 2025.

Nigel Newton, Chief Executive and PDMR, acquired 112,472 ordinary shares of 1.25 pence in the Company ("Ordinary Shares") (comprising 103,492 vested 2014 PSP shares and 8,980 dividend equivalent shares, both for nil consideration). Penny Scott-Bayfield, Group Finance Director and PDMR, acquired 70,252 Ordinary Shares (comprising 64,643 vested 2014 PSP shares and 5,609 dividend equivalent shares, both for nil consideration).

On 12 August 2025, Mr Newton and Ms Scott-Bayfield sold 50,867 and 33,185 Ordinary Shares respectively at a share price of £4.764739 per share in order to fund the tax liabilities and administrative fees arising on vesting. Mr Newton and Ms Scott-Bayfield retained the balance of 61,605 and 37,067 Ordinary Shares respectively.

Following these transactions, the shareholdings of Mr Newton and Ms Scott-Bayfield's (including persons closely associated) in the Company are as follows:

PDMR

 

Total shareholding in the Company

Percentage of the Company's issued share capital

Nigel Newton

1,690,596 Ordinary Shares

2.07%

Penny Scott-Bayfield

260,442 Ordinary Shares

0.32%

 

This vesting was satisfied through the transfer of shares from the Bloomsbury Employee Benefit Trust.

 

Notifications

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nigel Newton

2

Reason for the notification

a)

Position/status

Chief Executive

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Sale of Ordinary Shares to meet tax and administrative fees.

c)

Price(s) and volume(s)

Price

No. of shares

£4.764739

50,867

d)

Aggregated information

- Aggregated volume

- Aggregated price

e)

Date of the transaction

12 August 2025

f)

Place of the transaction

London Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Penny Scott-Bayfield

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Sale of Ordinary Shares to meet tax and administrative fees.

c)

Price(s) and volume(s)

Price

No. of shares

£4.764739

33,185

d)

Aggregated information

- Aggregated volume

- Aggregated price

e)

Date of the transaction

12 August 2025

f)

Place of the transaction

London Stock Exchange

 

 

 

For further information, please contact:

Bloomsbury Publishing Plc

Maya Abu-Deeb, Group General Counsel & Company Secretary

maya.abu-deeb@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder/ Hattie Dreyfus / Emily Brooker

bloomsbury@hudsonsandler.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDIRDBDGUD
Date   Source Headline
22nd May 20268:38 amRNSHolding(s) in Company
20th May 20267:00 amRNSAppointment of Non-Executive Director
20th May 20267:00 amRNSAudited Preliminary Results
12th May 20267:00 amRNSNotice of Preliminary Results
30th Apr 20262:47 pmRNSHolding(s) in Company
23rd Apr 202612:25 pmRNSHolding(s) in Company
15th Apr 202612:49 pmRNSAppointment of Executive Director - Replacement
15th Apr 20267:00 amRNSAppointment of Executive Director
1st Apr 20269:00 amRNSHolding(s) in Company
24th Mar 20267:22 amRNSHolding(s) in Company
19th Mar 20261:15 pmRNSHolding(s) in Company
5th Mar 20267:00 amRNSTrading Update
18th Feb 20265:51 pmRNSHolding(s) in Company
13th Feb 202610:21 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Feb 20264:39 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNS-RBloomsbury to grow Academic sales in Asia
8th Dec 202510:05 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSGoogle and Bloomsbury Strategic Collaboration
19th Nov 202511:53 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSUnaudited Interim Results
8th Oct 20257:00 amRNS-RAuthor Katherine Rundell announces multi-film deal
2nd Oct 20255:22 pmRNSHolding(s) in Company
22nd Sep 20254:20 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSAppointment of Chief Financial & Operating Officer
29th Aug 20253:39 pmRNSDirector/PDMR Shareholding
28th Aug 20254:16 pmRNSDirector/PDMR Shareholding
28th Aug 20253:51 pmRNSDirector/PDMR Shareholding
15th Aug 20259:34 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Aug 202512:11 pmRNSDirector/PDMR Shareholdings - Correction
12th Aug 20254:29 pmRNSDirector/PDMR Shareholding
11th Aug 202511:08 amRNSDirector/PDMR Shareholding
5th Aug 202511:31 amRNSHolding(s) in Company
1st Aug 20251:14 pmRNSDirector/PDMR Shareholding
31st Jul 202511:10 amRNSDirector/PDMR Shareholding
30th Jul 20253:55 pmRNSHolding(s) in Company
29th Jul 20253:08 pmRNSHolding(s) in Company
28th Jul 20254:39 pmRNSHolding(s) in Company
25th Jul 20253:13 pmRNSHolding(s) in Company
24th Jul 20253:48 pmRNSHolding(s) in Company
17th Jul 20253:46 pmRNSHolding(s) in Company
16th Jul 20253:16 pmRNSResults of the 2025 Annual General Meeting
16th Jul 20257:00 amRNSAGM Trading Update
15th Jul 20254:14 pmRNSHolding(s) in Company
4th Jul 20253:54 pmRNSHolding(s) in Company
2nd Jul 20254:39 pmRNSHolding(s) in Company
13th Jun 20255:33 pmRNSAnnual Financial Report
22nd May 20257:00 amRNSAnnual Financial Report
15th May 20257:00 amRNSNotice of Preliminary Results
15th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
20th Mar 20257:00 amRNSTrading Update and Board Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.